Article | May 19, 2021

Pandemic Demand Forces Rapidly Increased Production And Expertise

Source: Cytiva
iStock-1209969596-RT-qPCR-COVID-coronavirus-test

To combat COVID-19, the life sciences industry rapidly changed its pace. Solis BioDyne, one of the leading reagent suppliers in Europe, manufactures PCR/qPCR reagents and specifically a ribonuclease inhibitor used for COVID-19 RT-qPCR diagnostic tests. Previously manufactured at bench scale, the company now needed to quickly increase production 50-fold to meet the demand of COVID-19 tests. Solis BioDyne faced two challenges: safely producing this large volume and maintaining a very high quality.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: